AOBiome Therapeutics Inc.
PrivateLast Round
Series C
Jan 5, 2017
Total Funding Raised
$30M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AOBiome Therapeutics Inc. operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series C round in January 2017.
AOBiome Therapeutics Inc. is a biotechnology company that develops a novel class of therapeutics for inflammatory conditions, central nervous system disorders, and other systemic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Fashion & Beauty
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AOBiome Therapeutics Inc. Comparables
Compare AOBiome Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MatriSys Bioscience | 84% | |
| DermBiont | 84% | |
| Azitra, Inc. | 82% |
For institutional investors. Book with your work email.
AOBiome Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 5, 2017 | ||||
| VC Round | Sep 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 165% MoM, reaching 5.2K.
- Jun 22, 2026
Monthly visitors grew 49% MoM.
For institutional investors. Book with your work email.
AOBiome Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AOBiome Therapeutics Inc.'s valuation, stock price, and market status.
Is AOBiome Therapeutics Inc. a public or private company?
AOBiome Therapeutics Inc. is a private company.
What is the current stock price of AOBiome Therapeutics Inc.?
AOBiome Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks AOBiome Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AOBiome Therapeutics Inc. worth (valuation)?
Valuation information for AOBiome Therapeutics Inc. is not publicly available.
Can I buy AOBiome Therapeutics Inc. stock?
AOBiome Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AOBiome Therapeutics Inc.'s last funding round?
AOBiome Therapeutics Inc.'s most recent funding round was Series C on January 5, 2017.
Who are the main investors in AOBiome Therapeutics Inc.?
Investor information for AOBiome Therapeutics Inc. is not publicly disclosed.
Will AOBiome Therapeutics Inc. IPO soon?
No public IPO plans have been announced for AOBiome Therapeutics Inc..
How can I track AOBiome Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in AOBiome Therapeutics Inc.'s shares on secondary markets.